DiaMedica Therapeutics Inc. (DMAC)
NASDAQ·Healthcare·Biotechnology
$6.25
-1.11%
Mkt Cap $341.08M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$0.17 | -$0.17 | +0.00% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.15 | -$0.17 | -13.33% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.18 | -$0.18 | +0.00% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.18 | -$0.18 | +0.00% | — | — |
| Q1 2025 Mar 17, 2025 | — | — | — | -$0.17 | -$0.18 | -5.88% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.15 | -$0.15 | +0.00% | — | — |
| Q3 2024 Aug 7, 2024 | — | — | — | -$0.16 | -$0.13 | +18.75% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.16 | -$0.14 | +12.50% | — | — |
| Q1 2024 Mar 19, 2024 | — | $30.84M | — | -$0.14 | -$0.14 | +0.00% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.14 | -$0.12 | +14.29% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.22 | -$0.16 | +27.27% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.16 | -$0.20 | -25.00% | — | — |
| Q1 2023 Mar 28, 2023 | — | — | — | -$0.14 | -$0.14 | +0.00% | — | — |
| Q4 2022 Nov 9, 2022 | — | $76.00K | — | -$0.13 | -$0.12 | +7.69% | — | — |
| Q3 2022 Aug 10, 2022 | — | $13.00K | — | -$0.16 | -$0.13 | +18.75% | — | — |
| Q2 2022 May 4, 2022 | — | — | — | -$0.20 | -$0.13 | +35.00% | — | — |
| Q1 2022 Mar 14, 2022 | — | — | — | -$0.16 | -$0.10 | +37.50% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.23 | -$0.18 | +21.74% | — | — |
| Q3 2021 Aug 11, 2021 | — | — | — | -$0.19 | -$0.17 | +10.53% | — | — |
| Q2 2021 May 5, 2021 | — | — | — | -$0.23 | -$0.19 | +17.39% | — | — |